Feasibility study of using the PREDICT kidney tool for patients with localised renal cell carcinoma

We aim to recruit 60 patients from three hospitals in England and Scotland. Patients treated with surgery for primary localised clear-cell RCC awaiting their first follow-up appointment will be invited to take part. Participants will be allocated into two groups: standard care and standard care supplemented with the use of the PREDICT Kidney tool. Data will be collected through questionnaires, audio/video recordings of consultations and interviews with a subset of patients and clinicians. The study period is planned from September 2024 to July 2025. The findings will guide the design of a future randomised controlled trial to evaluate the tool's efficacy in clinical settings.

Authors

Institutions

Publication Details

Journal
BJUI Compass
Published
2025-03-30
DOI
https://doi.org/10.1002/bco2.70014
Citations
1
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Feasibility study of using the PREDICT kidney tool for patients with localised renal cell carcinoma

James P. Blackmur, Georgia Stimpson, Panayiotis Laouris, Juliet A. Usher‐Smith et al.
1 citations
BJUI Compass
Renal cell carcinoma treatment
1.52
article

Feasibility study of using the PREDICT kidney tool for patients with localised renal cell carcinoma

James P. Blackmur, Georgia Stimpson, Panayiotis Laouris, Juliet A. Usher‐Smith, Chiara Re, Hannah Harrison, Carley Batley, Axel Bex, Grant Duncan Stewart, Alexander Laird
article en
1 citations

Abstract

We aim to recruit 60 patients from three hospitals in England and Scotland. Patients treated with surgery for primary localised clear-cell RCC awaiting their first follow-up appointment will be invited to take part. Participants will be allocated into two groups: standard care and standard care supplemented with the use of the PREDICT Kidney tool. Data will be collected through questionnaires, audio/video recordings of consultations and interviews with a subset of patients and clinicians. The study period is planned from September 2024 to July 2025. The findings will guide the design of a future randomised controlled trial to evaluate the tool's efficacy in clinical settings.

BJUI CompassVol. 6(4)
NHS Lothian (GB), Royal Free London NHS Foundation Trust (GB), University of Cambridge (GB), Western General Hospital (GB), Edinburgh Cancer Research (GB), Addenbrooke's Hospital (GB), University College London (GB)
NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, Mark Foundation For Cancer Research, National Institute for Health and Care Research, Medical Research Centre, NIHR Cambridge Biomedical Research Centre, Cancer Research UK Cambridge Institute, University of Cambridge
Good health and well-being
Openalex Percentile: Top 20%
Renal cell carcinoma treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.